Xconomy National

Archives

by in

Entry	Author	Date	Location
Editor’s Picks: Xconomy Boston’s Top 20ish Stories of 2011	Gregory T. Huang	12/28/11	Boston
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News	Bruce V. Bigelow	11/10/11	San Diego
TEDMED Walking, FDA Clears Pacira Drug, Zogenix Close to NDA, & More San Diego Life Sciences News	Bruce V. Bigelow	11/03/11	San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Second Quarter	Gregory T. Huang	07/01/11	Boston
Concert Pharmaceuticals Hits $4 Million Milestone in GSK Alliance	Arlene Weintraub	06/20/11	Boston
Nestlé Acquires Prometheus, Trius Raises $30M in Private Placement, Canaan’s Bloch Discusses Advanced BioHealing Deal, & More San Diego Life Sciences News	Bruce V. Bigelow	05/26/11	San Diego
Polaris Prepares for Liver Cancer Trial, Goal Draws Near for Hepatitis C Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	04/28/11	San Diego
The New Tech Bubble, Biotech Vs. Big Pharma, and More Thoughts from Boston BD Conference	Gregory T. Huang	04/14/11	Boston
Vertex CF Drug Delivers, Follica Patent Application Reveals Tech, RXi Buys Apthera, & More Boston-Area Life Sciences News	Erin Kutz	04/01/11	Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the First Quarter	Gregory T. Huang	03/31/11	Boston
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News	Erin Kutz	02/25/11	Boston
FDA Rejects Orexigen’s Weight-Loss Drug, Arena Lays Off 66, ResMed CEO Jumps to CareFusion, & More San Diego Life Sciences News	Bruce V. Bigelow	02/03/11	San Diego
The World’s Most Innovative City	Tim Rowe	02/02/11	Boston
Editor’s Picks: Xconomy Boston’s Top 20 Stories of 2010	Gregory T. Huang	12/27/10	Boston
Zogenix Goes Public, Amira Restructures, Apricus Gets Boost From FDA Agreement on Cancer Drug Trial, & More San Diego Life Sciences News	Bruce V. Bigelow	11/24/10	San Diego
Xconomy Boston’s Top 20 Stories of the Third Quarter: From A123 Expansion to Zynga Acquisition	Gregory T. Huang	10/01/10	Boston
Vertex Tops Merck	Ryan McBride	08/04/10	Boston
Vertex Pursues Drug-Cocktail Strategy, Phase Forward Out To Expand Health IT Empire, Alkermes Awaits FDA Ruling, & More Boston-Area Life Sciences News	Rebecca Zacks	03/12/10	Boston
A Graceful Exit for Gloucester, Pink Slips at Sermo, A Half a Billion Bucks for Vertex, & More Boston-Area Life Sciences News	Rebecca Zacks	12/09/09	Boston
Amylin Forms Global Alliance in Obesity Drug Development; TEDMED’s Show Will Go On, Sequenom Sued for Civil Fraud, & More San Diego Biotech News	Bruce V. Bigelow	11/05/09	San Diego
Merck Makes GlycoFi Center of its Biogenerics Strategy, Biogen Says Tysabri Might Promote Remyelination, Stemgent Teams with Fate, & More Boston-Area Life Sciences News	Rebecca Zacks	04/30/09	Boston
Let’s Talk About Tomorrow, People—at Next Week’s Xconomy Biotech Forum	Rebecca Zacks	04/24/09	Boston
Vertex Offering Up To $220M	Rebecca Zacks	09/22/08	Boston
Vertex Raises $191 Million in Stock Offering	Luke Timmerman	09/18/08	Boston
Vertex To Sell 7 Million Shares of Stock	Luke Timmerman	09/17/08	Boston
Vertex Fending Off Competitors By Treating the Toughest Patients With Hepatitis C	Luke Timmerman	09/09/08	Boston
Vertex on the Rise, Sirtris on TV, an IPO (Finally) on the Table, and More Life Sciences News	Rebecca Zacks	04/02/08	Boston
Vertex Climbs on Encouraging Early Results From Cystic Fibrosis Drug Trial	Rebecca Zacks	03/27/08	Boston
Biogen Idec, Vertex, and Genzyme Try Different Ways to Skin the Innovation Cat	Rebecca Zacks	12/19/07	Boston
Page 1 of 1